Lizzo didn’t sample it, didn’t lip sync it, didn’t drop it in the background of a thirst trap. She remade UCB’s “Sexy Lady.” ...

UCB agreed to acquire Candid Therapeutics, a privately held clinical-stage biotechnology company focused on autoimmune and inflammatory diseases, for up to $2.2 billion, the companies said Sunday. The ...

After a recent streak of buyouts by some of Big Pharma's serial acquirers, Belgium's UCB is getting in on the action with a Friday acquisition potentially worth more than $1 billion. Building on its ...

G lobal biopharmaceutical giant UCB, Inc. plans to invest $2 billion in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility. The investment will generate 330 new jobs ...

UCB plans to build a $2 billion manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the first plant in the U.S. for the Belgium-based company and will produce ...

After UCB’s Bimzelx scored five approvals in just two years, the Belgian drugmaker has quickly made a blockbuster out of its up-and-coming immunology powerhouse. As the first med to selectively ...

Abstract: Mobile Edge Computing (MEC) is an emerging network architecture designed to enhance Quality of Service (QoS) by bringing computational resources and storage closer to end users. In MEC ...

`oops, just found the 'maxscore' didn't update, although the code has passed all the tests. update, modified score and maxScore funtions update, misunderstood the game score rule, actually the first ...

Biogen and UCB’s gamble on advancing into phase 3 on the back of a failed study looks to have paid off, with the partners reporting positive top-line results in systemic lupus erythematosus (SLE) and ...

Efficient Learning Algorithms for the Best Capped Base-Stock Policy in Lost Sales Inventory Systems Periodic review, lost sales inventory systems with lead times are notoriously challenging to ...

Natural Language Processing (NLP) focuses on the interaction between computers and humans through natural language. It encompasses tasks such as translation, sentiment analysis, and question answering ...

Following a delay and an initial rejection, UCB’s IL-17A/IL-17F blocker bimekizumab was approved for moderate-to-severe plaque psoriasis, which will now be marketed with the brand name Bimzelx. The ...